Biweekly dose of TAS-102 reduces toxicity and remains effective for treatment of colorectal cancer, says study

Published Date: 06 Jun 2025

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with treatment using standard dosing schedules, ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An ancient signaling pathway and 20 years of research offer hope for rare cancer

2.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

5.

Prostate cancer detection with PET CT and PET MRI is comparable.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot